Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05929521 · ClinicalTrials.gov registry record · Early Phase 1
Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero
A Early Phase 1 study of Pre-exposure Prophylaxis and Sex Work, sponsored by University of Illinois at Chicago.
- Active
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05929521: Active Early Phase 1 study of Pre-exposure Prophylaxis and Sex Work, sponsored by University of Illinois at Chicago.
NCT05929521 is a Early Phase 1 study of Pre-exposure Prophylaxis and Sex Work that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 24 participants, below the 192-participant average among 12 other Pre-exposure Prophylaxis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05929521, a Early Phase 1 study of Pre-exposure Prophylaxis and Sex Work, is active but no longer recruiting, sponsored by University of Illinois at Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a participatory implementation science framework, I will test whether an adapted and community empowered group healthcare model, Centering PrEP+, is a feasible and acceptable health system intervention to improve the health of sex workers and their clients by increasing PrEP uptake and adherence. The conduct of this pilot study will provide an opportunity to gain experience with all aspects of intervention research, including recruitment, retention, implementing a randomization protocol, assessing measurement tools, delivering an intervention, and monitoring fidelity across two sites, tracking all metrics suggested by CONSORT, data collection and management of quantitative data from multiple sources (e.g., survey, laboratory), data analysis, and dissemination.
Primary Outcome
8-Item Center for Disease Control (CDC) Behavioral Risk Factor Surveillance System determining gender identity, age, race/ethnicity, education level and income
Conditions Studied
Interventions
- OTHER C-PrEP+
Study Locations (1)
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-12-12 |
| Est. Completion | 2025-12-31 |
| Phase | Early Phase 1 |
What the registry record for NCT05929521 still lists
NCT05929521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 192-participant average among 12 other Pre-exposure Prophylaxis trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Pre-exposure Prophylaxis appearing as the primary indexed condition, and to 1 intervention - of which C-PrEP+ is the first listed.
NCT05929521 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05929521 about?
NCT05929521 is a clinical study titled "Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero". Using a participatory implementation science framework, I will test whether an adapted and community empowered group healthcare model, Centering PrEP+, is a feasible and acceptable health system intervention to improve the health of sex workers and their clients by increasing PrEP uptake and adheren...
What is the current status of trial NCT05929521?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2024-12-12. Estimated completion is 2025-12-31.
What conditions does trial NCT05929521 study?
This clinical trial studies the following conditions: Pre-exposure Prophylaxis, Sex Work.
What interventions are being tested in trial NCT05929521?
The interventions under investigation include: C-PrEP+ (OTHER).
Who is sponsoring clinical trial NCT05929521?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05929521 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pre-exposure Prophylaxis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05929521's enrollment target sits among peer trials
24 11th of 12 higher than 2 of 12 other Pre-exposure Prophylaxis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pre-exposure Prophylaxis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of a New "Boosting" Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers
COMPLETED · Early Phase 1
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
-
Stick2PrEP Cisgender Women and Trans Individuals
RECRUITING · NA
-
Predictors of Health Service Utilizations Among Key Population in Washington DC
RECRUITING
-
Gathering Online for Dialogue and Discussion to Enhance Social Support
RECRUITING · NA
-
Case Management Dyad
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI